Why BGPT?
logo

Review Papers Against Their Own Results

Check whether claims match experiments, exact reported results, and stated limitations.Know what the science actually supports before you trust the answer.

Press Enter ↡ to review paper


     Quick Explanation



    Augustine et al.'s 2019 Molecules review provides a broad, well-organized synthesis of pH-responsive polypeptide nanocarriers (PLL, pHis, pArg, pAsp, pGlu) for theranostics, citing ~216 works and clearly mapping organ-, tissue-, and cellular-level release strategies . As a narrative review it is useful for orientation but limited by non-systematic selection and weak reproducibility context.


     Long Explanation



    Evidence Base and Structure

    This narrative review (Augustine, Kalva, Kim H.A., Zhang, Kim I.; Molecules, 15 Aug 2019) consolidates pH-responsive polypeptide nanocarrier design with 216 references and declares no conflicts of interest . The authors organize carriers by amino acid chemistryβ€”cationic (PLL, pHis, pArg, pTyr, pPro, pTrp) and anionic (pAsp, pGlu)β€”then map release by organ (GI tract), tissue (tumor), and cellular (endosomal) pH, a taxonomy that genuinely aids navigation of a scattered field.

    The cited targeted cRGD-decorated polyion complex micelle exemplifies the field's promise: ~95% encapsulation, 97 nm DLS size, and acid-triggered DOX release (51% at pH 7.4 β†’ 96% at pH 5.5) with no observed organ toxicity in nude mice (n=6/group) . A companion pGlu/PNIPAM graft-copolymer study shows dual pH/thermo crosslinked micelles (~70 nm) tunable by pH and temperature .

    Critical Gaps

    As the authors themselves concede, drug loading and release remain suboptimal, NCA monomer synthesis is moisture-sensitive, and scale-up/biosafety is unresolved . Notably, no pH-responsive polypeptide nanocarrier from this literature pool appears in the registered clinical-trial snapshot provided (NCT03037281, NCT00102596, NCT05289869, NCT05211843, NCT03693612, NCT06889779, NCT02666976, NCT00036738)β€”all unrelated indicationsβ€”supporting the review's own translational-gap conclusion. Published in vivo efficacy rests mostly on single xenograft models with n=6 groups , so confidence in clinical extrapolation is low. Counterpoint: the review's breadth (216 refs) partially compensates for its non-systematic method, but citation bias toward positive results is acknowledged and unverifiable here.

    Verdict

    A competent, well-structured orienting review of high topical value in 2019; the pH-gate mechanism it describes (e.g., histidine imidazole protonation, hydrazone cleavage) is mechanistically sound, but the field's reproducibility and standardization remain its weak links .



    Feedback:    

    Updated: October 23, 2026



     BGPT Paper Review



    Study Novelty

    50%

    Aggregates ~200 primary papers on a well-established topic (pH-responsive polypeptides); the organ/tissue/cell taxonomy is a modest organizing contribution rather than new science.



    Scientific Quality

    70%

    Well-organized with 216 references and honest limitations, but narrative (non-systematic) selection, self-citation of authors' own work, and duplicated/erroneous passages in the text reduce rigor.



    Study Generality

    70%

    Covers many polypeptide chemistries and delivery levels, offering broadly transferable design principles, though focused on theranostic drug delivery rather than fundamental polymer physics.



    Study Usefulness

    60%

    Useful as an entry-point map for researchers in stimuli-responsive delivery; limited actionable quantitative benchmarking for formulators.



    Study Reproducibility

    30%

    Narrative reviews inherently lack reproducible primary data; cross-study metrics (loading %, sizes, release profiles) are reported inconsistently and not standardized.



    Explanatory Depth

    60%

    Mechanisms (protonation, helix-coil, hydrazone/disulfide cleavage, proton sponge) are described qualitatively without quantitative kinetic or thermodynamic treatment.


    🎁 Authors: Collect 52 Free Science Tokens (β‰ˆ $5.2 USD)

    Claim My Author Tokens

    Use for 13 days of free BGPT access (4 tokens = 1 day) or trade/sell (β‰ˆ $5.2 USD)

     Top Data Sources ExportMCP



     Hypothesis Graveyard



    Assumption that pH-triggered tumor release alone drives in vivo efficacy: contradicted by evidence that targeted ligands (cRGD) and uptake, not just pH gating, determine cytotoxicity (cRGD-PICM/DAD viability 23% vs PICM/DAD 57%).

     Science Art


    Paper Review: pH-Responsive Polypeptide-Based Smart Nano-Carriers for Theranostic Applications Science Art

     Science Movie



    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT